276 related articles for article (PubMed ID: 8501975)
21. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of "biphenotypic" acute leukemia cell lines with a variant Ph translocation t(9;22;10) (q34;q11;q22).
Ariyasu T; Matsuo Y; Harashima A; Nakamura S; Takaba S; Tsubota T; Orita K
Hum Cell; 1998 Mar; 11(1):43-50. PubMed ID: 9710720
[TBL] [Abstract][Full Text] [Related]
23. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
24. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
25. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
Laneuville P; Sullivan AK
Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
[TBL] [Abstract][Full Text] [Related]
26. Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis.
Ohno T; Hada S; Sugiyama T; Mizumoto T; Furukawa H; Nagai K
Am J Hematol; 1998 Apr; 57(4):320-5. PubMed ID: 9544977
[TBL] [Abstract][Full Text] [Related]
27. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
28. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
Chin YM; Bosco JJ; Koh CL
Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
[TBL] [Abstract][Full Text] [Related]
29. Chronic myelogenous leukemia as gene activation model in oncology minireview.
Zámecníková A
Neoplasma; 2000; 47(5):269-73. PubMed ID: 11130241
[TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review.
Secker-Walker LM; Craig JM
Leukemia; 1993 Feb; 7(2):147-51. PubMed ID: 8426467
[TBL] [Abstract][Full Text] [Related]
32. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
33. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
34. [Philadelphia chromosome positive acute mixed lineage leukemia with bcr (M-BCR-1) rearrangement].
Okada S; Shimizu T; Harada H; Miyoshi Y; Takizawa Y; Hagiwara S; Mori H; Niikura H; Terada H; Fujita K
Rinsho Ketsueki; 1990 Jan; 31(1):89-94. PubMed ID: 2156095
[TBL] [Abstract][Full Text] [Related]
35. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator.
Mills KI; Hynds SA; Burnett AK; MacKenzie ED; Birnie GD
Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475
[TBL] [Abstract][Full Text] [Related]
36. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
37. Acute leukaemia in bcr/abl transgenic mice.
Heisterkamp N; Jenster G; ten Hoeve J; Zovich D; Pattengale PK; Groffen J
Nature; 1990 Mar; 344(6263):251-3. PubMed ID: 2179728
[TBL] [Abstract][Full Text] [Related]
38. The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia.
Vigorito AC; Lorand-Metze I; Chauffaile ML; Costa FF; Saad ST
Haematologia (Budap); 1998; 29(2):123-32. PubMed ID: 9728804
[TBL] [Abstract][Full Text] [Related]
39. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
Suryanarayan K; Hunger SP; Kohler S; Carroll AJ; Crist W; Link MP; Cleary ML
Blood; 1991 Jan; 77(2):324-30. PubMed ID: 1985699
[TBL] [Abstract][Full Text] [Related]
40. Presence of cell lineage-specific hypomethylated sites in the major breakpoint cluster region.
Litz CE; Goldfarb AN; Strickler JG; Brunning RD
Cancer Res; 1990 Aug; 50(16):4984-90. PubMed ID: 2379163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
